Join
Live feed
·
INSIDERFilingvia Quantisnow
GeneDx Holdings Corp. logo

CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,319,291 worth of shares (17,179 units at $76.80) and converted options into 30,671 shares, increasing direct ownership by 30% to 58,447 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
WGS· GeneDx Holdings Corp.
Technology
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WGS (GeneDx Holdings Corp.) and more on Quantisnow.

CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,319,291 worth of shares (17,179 units at $76.80) and converted options into 30,671 shares, increasing direct ownership by 30% to 58,447 units (SEC Form 4) | Quantisnow